AKAM
64
2
DHI
47
6
NAVI
36
9
KEY
67
2
INTU
53
2
TROW
58
5
SBUX
44
3
FDX
54
-3
IVZ
55
-8
QCOM
46
2
EL
62
3
SLG
45
-3
YUM
52
2
LUV
71
10
CL
59
-3
SYY
53
-3
IR
63
-5
APD
55
3
TMO
60
2
MSFT
40
-4
AKAM
64
2
DHI
47
6
NAVI
36
9
KEY
67
2
INTU
53
2
TROW
58
5
SBUX
44
3
FDX
54
-3
IVZ
55
-8
QCOM
46
2
EL
62
3
SLG
45
-3
YUM
52
2
LUV
71
10
CL
59
-3
SYY
53
-3
IR
63
-5
APD
55
3
TMO
60
2
MSFT
40
-4
Financhill
Back

Terns Pharmaceuticals, Inc. 10K Form

Buy
61

TERN
Terns Pharmaceuticals, Inc.

Last Price:
$27.15
Seasonality Move:
24.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TERN News And Ratings

See the #1 stock for the next 7 days that we like better than TERN

TERN Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-19.8M
Price / Cash Flow: 0
Annual Sales: $3.25
Price / Book: 8.72

Profitability

EPS (TTM): -1.03200
Net Income (TTM): $-94.4M
Gross Margin: $-896K
Return on Equity: -29.05%
Return on Assets: -27.72%

Terns Pharmaceuticals, Inc. Earnings Forecast

Key Terns Pharmaceuticals, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 4 years.

Terns Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: TERN
Website: ternspharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 19.52
Quick Ratio: 19.21

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TERN Technical Analysis vs Fundamental Analysis

Buy
61
Terns Pharmaceuticals, Inc. (TERN) is a Buy

Is Terns Pharmaceuticals, Inc. a Buy or a Sell?